Supreme Court to hear Purdue’s opioid settlement appeal, Bloomberg reports

The Supreme Court has agreed to hear the appeal of Purdue Pharma’s $6B opioid settlement amid a Biden administration appeal that contends the settlement improperly shields the Sackler family members who own the company, Bloomberg’s Greg Stohr reports. Purdue’s bankruptcy reorganization plan includes the opioid settlement as well as an agreement by the Sacklers to give up ownership of the company.